
Prof. Dr. Peter F. Zipfel
Infection Biology · Head Directorate · Deputy Director International Leibniz Research School · Speaker
Phone: +49 3641 532-1301 Fax: +49 3641 532-2301 Email: peter.zipfel@leibniz-hki.de
- Immune escape of human pathogenic micro-organisms
- Infection-associated function of the complement system
- Genetic susceptibility for infections
Professional Career
Since 2000 | Professor for infection biology, Friedrich-Schiller-University Jena (FSU Jena) |
Since 2000 | Head of the department infection biology, Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
1999 | Nontenured professor, University Hamburg |
1993 | Habilitation in immunology and molecular biology, University Hamburg |
1989-2000 | Group head at the Bernhard-Nocht-Institute for tropical medicine Hamburg |
1989 | Visiting associate, Laboratory of Immunoregulation, National Institutes of Health, Bethesda, Maryland, USA |
1985-1988 | Postdoc, Laboratory of Immunoregulation, National Institutes of Health, Bethesda, Maryland, USA, funded by the German Academic Exchange Service (DAAD) |
1984 | PhD as Dr. rer. nat., University Bremen |
1980-1985 | Research assistant, University Bremen |
1980 | Diploma in biology, University Bremen |
Awards · Appointments · Scientific Activities
Since 2009 | Member at the editorial board of molecular immunology, frontiers in innate immunity |
2009 | Excellence award from the Deutsche Gesellschaft für Hygiene und Mikrobiologie |
Since 2008 | Representative of the graduate school International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) |
2008 | EFIS lecture award of the European Federation of Immunological Societies |
Since 2007 | Principal investigator of the excellence graduate school Jena School for Microbial Communication (JSMC) |
2007 | Heinz Spitzbart award of the European Society for Infectious Diseases in Obstetrics and Gynaecology (ESIDOG) |
Since 2006 | Principal investigator of the graduate school International Leibniz Research School for Microbial and Biomolecular Interactions (ILRS) |
2007-2011 | President of the European Complement Network |
2005 – 2012 | Board member of the European Complement Network |
2004 | Thuringian research award |
Since 2002 | Deputy Director of the Leibniz-Institute for Natural Product Research and Infection Biology – Hans-Knöll-Institute Jena |
Since 2000 | Project leader for infection biology, L2 |
1999-2001 | Member at the editorial board of experimental and clinical immunology, thrombosis and haemostasis, section editor molecular immunology Member of the European Working Party on the Genetics of Complement mediated Kidney Diseases, Deutsche Gesellschaft für Hygiene und Mikrobiologie (DGHM), Deutsche Gesellschaft für Immunologie, Gesellschaft für Genetik, Gesellschaft für Nephrologie |
(2020) A genome-wide association study identifies key modulators of complement factor h binding to malondialdehyde-epitopes. Proc Nat Acad Sci USA 117(18), 9942-9951. Details PubMed Open Access PDF
(2020) Long-term data on two sisters with C3GN due to an identical, homozygous CFH mutation and autoantibodies. Clini Nephrol 94(4), 197-206. Details PubMed
(2020) Immune modulation by complement receptor 3-dependent human monocyte TGF-ß1-transporting vesicles. Nat Commun 11(1), 2331. Details PubMed Open Access PDF
(2020) Complement in hemolytic and thrombotic related diseases. Front Immunol 11, 1212. Details PubMed
(2020) How does complement affect hematological malignancies: From basic mechanisms to clinical application. Front Immunol 11, 593610. Details PubMed Open Access PDF
(2020) In situ visualization o C3/C5 convertases to differentiate complement activation. Kidney Int Rep 5(6), 927-930. Details PubMed Open Access PDF
(2020) Acquisition of human plasminogen facilitates complement evasion by the malaria parasite Plasmodium falciparum. Eur J Immunol [In press] Details PubMed
(2020) Human neutrophils produce antifungal extracellular vesicles against Aspergillus fumigatus. mBio 11(2), e00596-20. Details PubMed Open Access PDF Supplement
(2020) Factor H-related protein 1: A complement protein and guardian of necrotic type surfaces. Br J Pharmacol [In press] Details PubMed
(2020) Quantification of factor H mediated self versus non-self discrimination by mathematical modeling. Front Immunol 11, 1911. Details PubMed Open Access
(2020) CFHR gene variations provide insights in the pathogenesis of the kidney diseases atypical hemolytic uremic syndrome and C3 glomerulopathy. J Am Soc Nephrol 31(2), 241-256. Details PubMed
(2019) Enolase from Aspergillus fumigatus is a moonlighting and immune evasion protein that binds the human plasma complement proteins factor H, FHL-1, C4BP, and plasminogen. Front Immunol 10, 2573. Details PubMed Open Access PDF
(2019) Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies. Nat Commun 10(1), 2961. Details PubMed Open Access PDF
(2019) Unaltered fungal burden and ethality in human CEACAM1-transgenic mice during Candida albicans dissemination and systemic infection. Front Microbiol 10, 2703. Details PubMed Open Access PDF
(2019) Molecular crypsis by pathogenic fungi using human factor H. PLOS One 14(2), e0212187. Details PubMed Open Access PDF
(2019) Bevacizumab-associated glomerular microangiopathy. Mod Pathol 32(5), 684-700. Details PubMed Open Access PDF
(2019) Thrombotische Mikroangiopathie: Was gibt es Neues? Der Nephrologe 14(1), 26-31. Details Open Access PDF
(2019) Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties. Sci Rep 9(1), 7056. Details PubMed Open Access PDF
(2019) Complement 5a receptor polymorphisms are associated with PVL-positive Staphylococcus aureus colonization in African Pygmies. Clin Infec Dis 68(5), 854-856. Details PubMed Open Access
(2019) C3 glomerulopathy – Understanding a rare complement-driven renal disease. Nat Rev Nephrol 15(3), 129-143. Details PubMed Open Access PDF
(2019) Recombinant production of MFHR1, a novel synthetic multitarget complement inhibitor, in moss bioreactors. Front Plant Sc 10, 260. Details PubMed Open Access PDF
(2019) Elucidating the immune evasion mechanisms of Borrelia mayonii, the causative agent of lyme disease. Front Immunol 10, 2722. Details PubMed Open Access PDF
(2019) ApoE attenuates unresolvable inflammation by complex formation with activated C1q. Nat Med 25(3), 496-506. Details PubMed Open Access PDF
(2019) The Case: A 78-year-old woman with acute kidney injury and hemolytic anemia. Kidney Int 95(2), 473-474. Details PubMed
(2019) C3-glomerulopathy autoantibodies mediate distinct effects on complement C3- and C5-convertases. Front Immunol 10, 1030. Details PubMed Open Access PDF
(2019) Complement inhibitors in clinical trials for glomerular diseases. Front Immunol 10, 2166. Details PubMed Open Access PDF
(2018) Aspf2 from Aspergillus fumigatus recruits human immune regulators for immune evasion and cell damage. Front Immunol 9, 1635. Details PubMed Open Access PDF Supplement
(2018) Modeling hemolytic-uremic syndrome: In-depth characterization of distinct murine models reflecting different features of human disease. Front Immunol 9, 1459. Details PubMed Open Access PDF Supplement
(2018) Playing 'hide-and-seek' with factor H: game-theoretical analysis of a single nucleotide polymorphism. J R Soc Interface 15(142), 20170963. Details PubMed Open Access
(2018) Kallikrein cleaves C3 and activates complement. J Innate Immun 10(2), 94-105. Details PubMed Open Access
(2018) The secreted Candida albicans protein Pra1 disrupts host defense by broadly targeting and blocking complement C3 and C3 activation fragments. Mol Immunol 93, 266-277. Details PubMed
(2018) Streptococcus pneumoniae from patients with hemolytic uremic syndrome binds human plasminogen via the surface protein PspC and uses plasmin to damage human endothelial cells. J Infect Dis 217(3), 358-370. Details PubMed Open Access
(2018) The MFHR1 fusion protein is a novel synthetic multitarget complement inhibitor with therapeutic potential. J Am Soc Nephrol 29(4), 1141-1153. Details PubMed Open Access
(2018) Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration. PLOS One 13(8), e0200739. Details PubMed Open Access PDF
(2018) FHR-1 binding impairs factor H-mediated complement evasion by the malaria parasite Plasmodium falciparum. J Immunol 201(12), 3497-3502. Details PubMed Open Access PDF
(2018) FHR5 binds to laminins, uses separate C3b and surface-binding sites, and activates complement on malondialdehyde-acetaldehyde surfaces. J Immunol 200(7), 2280-2290. Details PubMed Open Access PDF
(2018) Membranoproliferative glomerulonephritis and C3 glomerulopathy in children: Change in treatment modality? A report on a case series. Clin Kidney J 11(4), 479-490. Details PubMed Open Access PDF
(2018) Reply to kang and brooks: Comment on the interpretation of binding of Pra1, the fungal immune evasion protein from Candida albicans to the human C3 and on the conformational changes of C3 upon activation: Kang and brooks optimization of biolayer-interfero. Mol Immunol 101, 638-639. Details PubMed
(2017) Direct Binding of the pH-Regulated Protein 1 (Pra1) from Candida albicans Inhibits Cytokine Secretion by Mouse CD4(+) T Cells. Front Microbiol 8, 844. Details PubMed
(2017) Anaphylatoxins Activate Ca2+, Akt/PI3-Kinase, and FOXO1/FoxP3 in the Retinal Pigment Epithelium. Front Immunol 8, 703. Details PubMed
(2017) Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Kidney Int 91(3), 539-551. Details PubMed
(2017) Successful discontinuation of eculizumab under immunosuppressive therapy in DEAP-HUS. Pediatr Nephrol 32(6), 1081-1087. Details PubMed
(2017) Factor H Binds to Extracellular DNA Traps Released from Human Blood Monocytes in Response to Candida albicans. Front Immunol 7, 671. Details PubMed
(2017) Binding of Candida albicans to Human CEACAM1 and CEACAM6 Modulates the Inflammatory Response of Intestinal Epithelial Cells. mBio 8(2), pii: e02142-16. Details PubMed
(2017) Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders. J Am Soc Nephrol 28(5), 1462-1474. Details PubMed
(2017) Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator. J Neuroinflammation 14(1), 4. Details PubMed
(2017) Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction. J Innate Immun 9(1), 33-51. Details PubMed
(2017) Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties. Sci Rep 7(1), 303. Details PubMed
(2016) FHR3 Blocks C3d-Mediated Coactivation of Human B Cells. J Immunol 197(2), 620-629. Details PubMed
(2016) Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces. J Am Soc Nephrol 27(5), 1413-1425. Details PubMed
(2016) Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif. PLOS ONE 11(1), e0147709. Details PubMed
(2016) BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex. Mol Immunol 99, 407-424. Details PubMed
(2016) CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein J Infect Dis 213(9), 1388-1399. Details PubMed
(2016) The complement inhibitor factor H generates an anti-inflammatory and tolerogenic state in monocyte-derived dendritic cells J Immunol 196(10), 4274-4290. Details PubMed
(2016) Deciphering the counterplay of Aspergillus fumigatus infection and host inflammation by evolutionary games on graphs. Sci Rep 6, 27807. Details PubMed Open Access PDF Supplement
(2016) The Plasmodium falciparum blood stages acquire factor H family proteins to evade destruction by human complement. Cell Microbiol 18(4), 573-590. Details PubMed
(2016) Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases. Front Immunol 7, 542. Details PubMed
(2016) Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are Predictive. EBioMedicine 12, 227-238. Details PubMed
(2016) The complement receptor C5aR1 contributes to renal damage but protects the heart in angiotensin II-induced hypertension Am J Ren Physiol 310(11), F1356-F1365. Details PubMed
(2015) Susceptibility to invasive meningococcal disease: polymorphism of complement system genes and Neisseria meningitidis factor H binding protein. PLOS One 10(3), e0120757. Details PubMed
(2015) Host-pathogen interactions between the human innate immune system and Candida albicans - Understanding and modeling defense and evasion strategies Front Microbiol 6, 625. Details PubMed
(2015) Plant Protochlorophyllide Oxidoreductases A and B - Catalytic Efficiency and Initial Reaction Steps. J Biol Chem 290(47), 28530-28539. Details PubMed
(2015) Activation of endogenously expressed ion channels by active complement in the retinal pigment epithelium. Pflugers Arch 467(10), 2179-2191. Details PubMed
(2015) Pseudomonas aeruginosa Uses Dihydrolipoamide Dehydrogenase (Lpd) to Bind to the Human Terminal Pathway Regulators Vitronectin and Clusterin to Inhibit Terminal Pathway Complement Attack. PLOS One 10(9), e0137630. Details PubMed
(2015) Microarray based identification of human antibodies against Staphylococcus aureus antigens. Proteomics Clin Appl 9(11-12), 1003-1011. Details PubMed
(2015) Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein. PLOS One 10(9), e0138398. Details PubMed
(2015) Binding of vitronectin and Factor H to Hic contributes to immune evasion of Streptococcus pneumoniae serotype 3. Thromb Haemost 113(1), 125-142. Details PubMed
(2015) Sequence variations and protein expression levels of the two immune evasion proteins Gpm1 and Pra1 influence virulence of clinical candida albicans isolates PLOS One 10(2), e0113192. Details PubMed
(2015) Atypical aHUS: State of the art. Mol Immunol 67(1), 31-42. Details PubMed
(2015) Moraxella catarrhalis binds plasminogen to evade host innate immunity. Infect Immun 83(9), 3458-3469. Details PubMed
(2015) Complement the alternative Pathway Encyclopedia of Life Sciences; John Wiley & Sons, Ltd, Chichester [In press] Details
(2015) The role of complement in C3 glomerulopathy. Mol Immunol 67(1), 21-30. Details PubMed
(2014) Immune defence strategies of generalist and specialist insect herbivores. Proc Biol Sci 281(1788), 20140897. Details PubMed
(2014) Outer Membrane Protein OlpA Contributes to Moraxella catarrhalis Serum Resistance via Interaction With Factor H and the Alternative Pathway. J Infect Dis 210(8), 1306-1310. Details PubMed
(2014) Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J Clin Invest 124(1), 145-155. Details PubMed
(2014) Identification of a Haemophilus influenzae factor H-Binding lipoprotein involved in serum resistance. J Immunol 192(12), 5913-5923. Details PubMed
(2014) Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes. Infect Immun 82(1), 380-392. Details PubMed
(2014) Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin. PLOS One 9(3), e90796. Details PubMed
(2014) New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases. Mol Immunol 62(1), 235-248. Details PubMed
(2014) Tuf of Streptococcus pneumoniae is a surface displayed human complement regulator binding protein. Mol Immunol 62(1), 249-264. Details PubMed
(2014) Successful treatment of DEAP-HUS with eculizumab. Pediatr Nephrol 29(5), 841-851. Details PubMed
(2014) A novel antibody against human properdin inhibits the alternative complement system and specifically detects properdin from blood samples. PLOS One 9(5), e96371. Details PubMed
(2014) Interaction of Shiga toxin 2 with complement regulators of the factor H protein family. Mol Immunol 58(1), 77-84. Details PubMed
(2014) Standardisation of the factor H autoantibody assay. Immunobiology 219(1), 9-16. Details PubMed
(2014) Human complement factor H and factor H-like protein 1 are expressed in human retinal pigment epithelial cells. Ophthalmic Res 51(2), 59-66. Details PubMed
(2014) Staphylococcus aureus: the multi headed hydra resists and controls human complement response in multiple ways. Int J Med Microbiol 304(2), 188-194. Details PubMed
(2013) Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration. Hum Mol Genet 22(23), 4857-4869. Details PubMed
(2013) Further structural insights into the binding of complement factor H by complement regulator-acquiring surface protein 1 (CspA) of Borrelia burgdorferi. Acta Crystallogr Sect F Struct Biol Cryst Commun 69(Pt 6), 629-633. Details PubMed
(2013) Human factor H-related protein 2 (CFHR2) regulates complement activation. PLOS One 8(11), e78617. Details PubMed
(2013) CspA from Borrelia burgdorferi inhibits the terminal complement pathway. MBio 4(4), Details PubMed
(2013) BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein. J Biol Chem 288(35), 25229-25243. Details PubMed
(2013) Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. J Am Soc Nephrol 24(1), 53-65. Details PubMed
(2013) Glycerol-3-phosphate dehydrogenase 2 is a novel factor H-, factor H-like protein 1-, and plasminogen-binding surface protein of Candida albicans. J Infect Dis 207(4), 594-603. Details PubMed
(2013) Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans. Mol Immunol 56(3), 161-169. Details PubMed
(2013) Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components. PLOS One 8(1), e53659. Details PubMed
(2013) Malaria parasites co-opt human factor H to prevent complement-mediated lysis in the mosquito midgut. Cell Host Microbe 13(1), 29-41. Details PubMed
(2013) The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J Biol Chem 288(22), 15614-15627. Details PubMed
(2013) Human complement control and complement evasion by pathogenic microbes - tipping the balance. Mol Immunol 56(3), 152-160. Details PubMed
(2013) Defective complement action and control defines disease pathology for retinal and renal disorders and provides a basis for new therapeutic approaches. Adv Exp Med Biol 735, 173-187. Details PubMed
(2013) 14th European Meeting on Complement in Human Disease, Jena, Germany, August 17-21, 2013. Mol Immunol 56(3), 151-151. Details PubMed
(2012) Plasminogen is a complement inhibitor. J Biol Chem 287(22), 18831-18842. Details PubMed
(2012) Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J Immunol 188(1), 379-385. Details PubMed
(2012) Candida albicans scavenges host zinc via Pra1 during endothelial invasion. PLOS Pathog 8(6), e1002777. Details PubMed Open Access
(2012) Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther 14(4), R185. Details PubMed
(2012) Dihydrolipoamide dehydrogenase of Pseudomonas aeruginosa is a surface-exposed immune evasion protein that binds three members of the factor H family and plasminogen. J Immunol 189(10), 4939-4950. Details PubMed
(2012) Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi. Clin Dev Immunol 2012, 349657. Details PubMed
(2012) Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumab. Am J Transplant 12(9), 2546-2553. Details PubMed
(2012) Yersinia enterocolitica YadA mediates complement evasion by recruitment and inactivation of C3 products. J Immunol 189(10), 4900-4908. Details PubMed
(2011) Different factor H-related protein patterns in siblings with typical hemolytic uremic syndrome. Pediatr Nephrol 26(8), 1345-1347. Details PubMed
(2011) Complement in age-related macular degeneration: a focus on function. Eye (Lond) 25(6), 683-693. Details PubMed
(2011) Comparative and functional genomics provide insights into the pathogenicity of dermatophytic fungi. Genome Biol 12(1), R7. Details PubMed
(2011) Production of biologically active recombinant human factor H in Physcomitrella. Plant Biotechnol J 9(3), 373-383. Details PubMed
(2011) Combined C3b and factor B autoantibodies and MPGN type II. N Engl J Med 365(24), 2340-2342. Details PubMed
(2011) Immune evasion of Moraxella catarrhalis involves ubiquitous surface protein A-dependent C3d binding. J Immunol 186(5), 3120-3129. Details PubMed
(2011) Complement regulation at necrotic cell lesions is impaired by the age-related macular degeneration-associated factor-H His402 risk variant. J Immunol 187(8), 4374-4383. Details PubMed
(2011) Role of pH-regulated antigen 1 of Candida albicans in the fungal recognition and antifungal response of human neutrophils. Mol Immunol 48(15-16), 2135-2143. Details PubMed
(2011) The pH-regulated antigen 1 of Candida albicans binds the human complement inhibitor C4b-binding protein and mediates fungal complement evasion. J Biol Chem 286(10), 8021-8029. Details PubMed
(2011) Monomeric C-reactive protein modulates classic complement activation on necrotic cells. FASEB J 25(12), 4198-4210. Details PubMed
(2011) Immunevasion des Gram-positiven Bakteriums Staphylococcus aureus und der multiresistenten Formen MRSA. Medizinisch-orthopädische Technik 131, 22-22. Details
(2011) Haemophilus influenzae protein E recognizes the C-terminal domain of vitronectin and modulates the membrane attack complex. Mol Microbiol 81(1), 80-98. Details PubMed
(2011) Conidial dihydroxynaphthalene melanin of the human pathogenic fungus Aspergillus fumigatus interferes with the host endocytosis pathway. Front Microbiol / Fungi and their interactions 2, 96. Details PubMed
(2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478(7367), 76-81. Details PubMed
(2011) Immune escape of the human facultative pathogenic yeast Candida albicans: the many faces of the Candida Pra1 protein. Int J Med Microbiol 301(5), 423-430. Details PubMed
(2011) Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura? Pediatr Nephrol 26(11), 1947-1956. Details PubMed
(2010) Secreted Aspergillus fumigatus protease Alp1 degrades human complement proteins C3, C4, and C5. Infect Immun 78(8), 3585-3594. Details PubMed
(2010) Interaction of phagocytes with filamentous fungi. Curr Opin Microbiol 13(4), 409-415. Details PubMed
(2010) Binding of the human complement regulators CFHR1 and factor H by streptococcal collagen-like protein 1 (Scl1) via their conserved C termini allows control of the complement cascade at multiple levels. J Biol Chem 285(49), 38473-38485. Details PubMed
(2010) Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PLOS One 5(10), e13519. Details PubMed
(2009) The yeast Candida albicans evades human complement attack by secretion of aspartic proteases. Mol Immunol 47(2-3), 465-475. Details PubMed
(2006) The vesicle transport protein Vac1p is required for virulence of Candida albicans. Microbiology 152(Pt 10), 3111-3121. Details PubMed
(2006) Two factor H-related proteins from the mouse: expression analysis and functional characterization. Immunogenetics 58(11), 883-893. Details PubMed
(2005) Generation and functional in vivo characterization of a lipid kinase defective phosphatidylinositol 3-kinase Vps34p of Candida albicans. Microbiology 151(Pt 1), 81-89. Details PubMed
(2005) The putative vacuolar ATPase subunit Vma7p of Candida albicans is involved in vacuole acidification, hyphal development and virulence. Microbiology 151(Pt 5), 1645-1655. Details PubMed